Mats Gunnar Pettersson
Director/Miembro de la Junta en MAGLE CHEMOSWED HOLDING AB .
Origen de la red de primer grado Mats Gunnar Pettersson.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 40 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Medical Specialties | 16 | |
16
| Subsidiary | Biotechnology | 16 |
| Public Company | Biotechnology | 15 | |
| Public Company | Pharmaceuticals: Major | 13 | |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.
13
| Extinct | Miscellaneous Commercial Services | 13 |
Magle Chemoswed AB
 Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The company is based in Lund, Sweden.
3
| Subsidiary | Medical Specialties | 3 |
Magle AB
 Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The company is based in Lund, Sweden.
2
| Subsidiary | Chemicals: Major Diversified | 2 |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.
1
| Extinct | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mats Gunnar Pettersson a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TDC A/S | Major Telecommunications | Chairman Director/Board Member Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Director/Board Member Public Communications Contact General Counsel | |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Pharmaceuticals: Other | Director/Board Member Chief Operating Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Chairman Director/Board Member Director/Board Member | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| Karolinska Institutet | College/University | Chairman Director/Board Member Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree Masters Business Admin | |
| University of Aarhus | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Director/Board Member Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Université Libre de Bruxelles | College/University | Undergraduate Degree Graduate Degree | |
| University of Southern Denmark | College/University | Graduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| Kabi Pharmacia | General Counsel Chief Executive Officer | ||
Ferrosan International A/S
 Ferrosan International A/S Pharmaceuticals: MajorHealth Technology Ferrosan International A/S engages in the manufacture and supply of consumer healthcare products and medical devices. The company was founded in 1920 and is headquartered in Moscow, Russia. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Malmö Högskola | College/University | Director/Board Member Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Adroit Science AB
 Adroit Science AB Miscellaneous Commercial ServicesCommercial Services Adroit Science AB offers laboratory and consultancy services. The private company is based in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Serendipity Partners
 Serendipity Partners Investment ManagersFinance Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor Chief Executive Officer Private Equity Investor | |
| Nicachet AB | Director/Board Member Chairman | ||
| Shieldheart Medtech AB | Director/Board Member Chairman | ||
| CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Estadísticas
Internacional
| Suecia | 22 |
| Dinamarca | 16 |
| Estados Unidos | 6 |
| Reino Unido | 4 |
| Noruega | 4 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 15 |
| Commercial Services | 5 |
| Finance | 3 |
| Communications | 2 |
Operativa
| Director/Board Member | 570 |
| Chairman | 257 |
| Corporate Officer/Principal | 177 |
| Independent Dir/Board Member | 142 |
| Chief Executive Officer | 95 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Mats Gunnar Pettersson
- Conexiones Empresas
